|
1
|
Thakkar JP, Dolecek TA, Horbinski C,
Ostrom QT, Lightner DD, Barnholtz-Sloan JS and Villano JL:
Epidemiologic and molecular prognostic review of glioblastoma.
Cancer Epidemiol Biomarkers Prev. 23:1985–1996. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Verhoeff JJ, van Tellingen O, Claes A,
Stalpers LJ, van Linde ME, Richel DJ, Leenders WP and van Furth WR:
Concerns about anti-angiogenic treatment in patients with
glioblastoma multiforme. BMC Cancer. 9:4442009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ohka F, Natsume A and Wakabayashi T:
Current trends in targeted therapies for glioblastoma multiforme.
Neurol Res Int. 2012:8784252012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moinuddin FM, Shinsato Y, Komatsu M,
Mitsuo R, Minami K, Yamamoto M, Kawahara K, Hirano H, Arita K and
Furukawa T: ATP7B expression confers multidrug resistance through
drug sequestration. Oncotarget. 7:22779–22790. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakayama K, Kanzaki A, Terada K, Mutoh M,
Ogawa K, Sugiyama T, Takenoshita S, Itoh K, Yaegashi N, Miyazaki K,
et al: Prognostic value of the Cu-transporting ATPase in ovarian
carcinoma patients receiving cisplatin-based chemotherapy. Clin
Cancer Res. 10:2804–2811. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kanzaki A, Toi M, Neamati N, Miyashita H,
Oubu M, Nakayama K, Bando H, Ogawa K, Mutoh M, Mori S, et al:
Copper-transporting P-type adenosine triphosphatase (ATP7B) is
expressed in human breast carcinoma. Jpn J Cancer Res. 93:70–77.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohbu M, Ogawa K, Konno S, Kanzaki A,
Terada K, Sugiyama T and Takebayashi Y: Copper-transporting P-type
adenosine triphosphatase (ATP7B) is expressed in human gastric
carcinoma. Cancer Lett. 189:33–38. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shinsato Y, Furukawa T, Yunoue S, Yonezawa
H, Minami K, Nishizawa Y, Ikeda R, Kawahara K, Yamamoto M, Hirano
H, et al: Reduction of MLH1 and PMS2 confers temozolomide
resistance and is associated with recurrence of glioblastoma.
Oncotarget. 4:2261–2270. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Che XF, Zheng CL, Owatari S, Mutoh M,
Gotanda T, Jeung HC, Furukawa T, Ikeda R, Yamamoto M, Haraguchi M,
et al: Overexpression of survivin in primary ATL cells and sodium
arsenite induces apoptosis by down-regulating survivin expression
in ATL cell lines. Blood. 107:4880–4887. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Joshi K, Banasavadi-Siddegowda Y, Mo X,
Kim SH, Mao P, Kig C, Nardini D, Sobol RW, Chow LM, Kornblum HI, et
al: MELK-dependent FOXM1 phosphorylation is essential for
proliferation of glioma stem cells. Stem Cells. 31:1051–1063. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hegi ME, Diserens AC, Gorlia T, Hamou MF,
de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani
L, et al: MGMT gene silencing and benefit from temozolomide in
glioblastoma. N Engl J Med. 352:997–1003. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang P, Zhang W, Wang Y, Peng X, Chen B,
Qiu X, Li G, Li S, Wu C, Yao K, et al: IDH mutation and MGMT
promoter methylation in glioblastoma: Results of a prospective
registry. Oncotarget. 6:40896–40906. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao Y, Fotovati A, Lee C, Wang M, Cote G,
Guns E, Toyota B, Faury D, Jabado N and Dunn SE: Inhibition of
Y-box binding protein-1 slows the growth of glioblastoma multiforme
and sensitizes to temozolomide independent O6-methylguanine-DNA
methyltransferase. Mol Cancer Ther. 8:3276–3284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vulpe C, Levinson B, Whitney S, Packman S
and Gitschier J: Isolation of a candidate gene for Menkes disease
and evidence that it encodes a copper-transporting ATPase. Nat
Genet. 3:7–13. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bull PC, Thomas GR, Rommens JM, Forbes JR
and Cox DW: The Wilson disease gene is a putative copper
transporting P-type ATPase similar to the Menkes gene. Nat Genet.
5:327–337. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tanzi RE, Petrukhin K, Chernov I,
Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L,
Brzustowicz LM, et al: The Wilson disease gene is a copper
transporting ATPase with homology to the Menkes disease gene. Nat
Genet. 5:344–350. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Davies KM, Hare DJ, Cottam V, Chen N,
Hilgers L, Halliday G, Mercer JF and Double KL: Localization of
copper and copper transporters in the human brain. Metallomics.
5:43–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Owatari S, Akune S, Komatsu M, Ikeda R,
Firth SD, Che XF, Yamamoto M, Tsujikawa K, Kitazono M, Ishizawa T,
et al: Copper-transporting P-type ATPase, ATP7A, confers multidrug
resistance and its expression is related to resistance to SN-38 in
clinical colon cancer. Cancer Res. 67:4860–4868. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyashita H, Nitta Y, Mori S, Kanzaki A,
Nakayama K, Terada K, Sugiyama T, Kawamura H, Sato A, Morikawa H,
et al: Expression of copper-transporting P-type adenosine
triphosphatase (ATP7B) as a chemoresistance marker in human oral
squamous cell carcinoma treated with cisplatin. Oral Oncol.
39:157–162. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Veringa SJ, Biesmans D, van Vuurden DG,
Jansen MH, Wedekind LE, Horsman I, Wesseling P, Vandertop WP, Noske
DP, Kaspers GJ and Hulleman E: In vitro drug response and efflux
transporters associated with drug resistance in pediatric high
grade glioma and diffuse intrinsic pontine glioma. PLoS One.
8:e615122013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Henson JW, Cordon-Cardo C and Posner JB:
P-glycoprotein expression in brain tumors. J Neurooncol. 14:37–43.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sawada T, Kato Y, Sakayori N, Takekawa Y
and Kobayashi M: Expression of the multidrug-resistance
P-glycoprotein (Pgp, MDR-1) by endothelial cells of the
neovasculature in central nervous system tumors. Brain Tumor
Pathol. 16:23–27. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Daood M, Tsai C, Ahdab-Barmada M and
Watchko JF: ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2)
expression in the developing human CNS. Neuropediatrics.
39:211–218. 2008. View Article : Google Scholar : PubMed/NCBI
|
